Servier is an international, independent pharmaceutical group governed by a foundation. Present in more than 150 countries, it employs 21,900 people worldwide. Its growth is driven by a continuous commitment to cardiovascular and metabolic diseases, oncology, and neuroscience.
Servier is the second-largest French pharmaceutical group, with its headquarters, two production sites (96.5% of the active ingredients in the Group’s branded medicines are produced in France), and its new Paris-Saclay R&D Institute located in France. The Servier R&D Institute, situated at the heart of the Paris-Saclay innovation hub, reflects the Group’s determination to contribute to French research.
—
Servier is an international and independent pharmaceutical group governed by a Foundation. Established in more than 150 pays, Servier employs 21 900 people in the world. Its growth is based on a constant commitment to cardiovascular disease and metabolism, oncology and neuroscience. Servier is the second largest French pharmaceutical group, with its seat, two production sites (96,5 % of the active ingredients of the Group's original medicines are produced in France) and its new Institute of R&D Paris-Saclay established in France. The Institute of R&D Servier, at the heart of the Paris-Saclay innovation hub, testifies to the group's determination to participate in the influence of French research in the world.